These cases highlight how flexibly GLP-1 tech can spread globally, though quality equivalence must be demonstrated
Short-chain fatty acids are, among other things, ligands for the rhodopsin-like (Class A) GPCRs free fatty acid receptors (FFARs), expressed in the gut and the endocrine pancreas
Health Canada's Drug Product Database lists active drug identification numbers for Ozempic, Wegovy, Rybelsus, Mounjaro and Zepbound, so semaglutide and tirzepatide are both legally available north of the border
Preclinical research has demonstrated that GLP-1 receptor activation may confer neuroprotective effects through multiple mechanisms
In addition, mild to moderate gastrointestinal side effects were more frequent in the semaglutide-treated group compared to the placebo-treated group